NgoJanuwari 5, 2021, i-Shangke Biopharmaceutical (Shanghai) Co., Ltd. yaklonyeliswa nge-"(S)-1-tert-butoxycarbonyl-3-hydroxypiperidine" Shanghai High-tech Achievement Transformation Project.
Njengebhizinisi kazwelonke lobuchwepheshe obuphezulu, i-Suntech Biotech ihlala ithatha i-biotechnology ukuhola ukuthuthukiswa kwemboni yamakhemikhali nemithi, futhi iletha okuluhlaza nempilo kubantu njengomsebenzi wayo.Ukwandisa ibhizinisi ngezindlela eziningi, sebenzisana ngenkuthalo nezikole ezaziwayo kanye namabhizinisi ekhaya nakwamanye amazwe, njalo uthuthukisa amandla alo okuthuthuka, wandise ukucushwa kwangaphakathi kwebhizinisi, futhi ube ngcono futhi uqine.
Igama lephrojekthi: (S)-1-tert-Butoxycarbonyl-3-hydroxypiperidine
Inombolo yomthetho: 2020-10694
Izinga lento: B
Ukuthi kukhona izimpumelelo emkhakheni wobuchwepheshe obuphezulu onamalungelo okuvikela ubunikazi bokusungula ezimele: Yebo
Isicelo: (S) -1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) iyisiphakathi esibalulekile se-chiral sokuhlanganiswa kwe-ibrutinib APIs.I-Ibrutinib isidakamizwa esisha sokulwa nomdlavuza esiqondise ezenzweni ezimbi ze-B-cell esavunywa ngaphansi kwemvume esheshisiwe yi-US Food and Drug Administration (FDA) ngoNovemba 13, 2013 ukuze zelashwe i-lymphoma.
Incazelo yokuguqulwa kwempumelelo yobuchwepheshe obuphezulu
Ukuguqulwa kwezimpumelelo zobuchwepheshe obuphezulu kubhekisela enqubweni lapho amabhizinisi enza khona ukukhiqizwa nokusebenza kobuchwepheshe obuphezulu.Umbuso usekela amabhizinisi ukuthi aqalise ukuguqulwa kwezimpumelelo zesayensi nezobuchwepheshe ngokucwaninga nokuthuthukiswa okuzimele, ukunikeza amalayisense, ukuthatha amasheya ngentengo, kanye nokubambisana nezimboni, amanyuvesi kanye nezikhungo zocwaningo.Kumaphrojekthi okuguqulwa kwempumelelo yobuchwepheshe obuphezulu abuyekezwa futhi abikwa yibhizinisi, ngokuya ngokuphothulwa kwezinkomba zezomnotho eziphelele kanye nezici zamalungelo empahla yengqondo yephrojekthi, izinga lokusungula izinto ezintsha, njll., ukutshalwa kwezimali kwe-R&D kuhlobene nephrojekthi. -amalungelo empahla yobuhlakani ahlobene, izitifiketi zelungelo lobunikazi bokusungulwa, noma labo abangena esigabeni sokuhlolwa okukhulu.Isitifiketi sokuhlonipha esikhishwe ebhizinisini ngemuva kokubuyekezwa okuqinile kanye nophenyo olunzulu lwemakethe, njengezinto zobufakazi bokusebenza kwelungelo lobunikazi lokusungulwa, isitifiketi semodeli yensiza yelungelo lobunikazi, isitifiketi sokubhaliswa kwe-software ye-copyright, isitifiketi sokubhaliswa kwesakhiwo sesifunda esididiyelwe, njll.
Iphrofayela Yenkampani
I-Shangke Biomedical (Shanghai) Co., Ltd. yasungulwa ngo-2008 futhi itholakala e-International Medical Park, endaweni eseningizimu yeZhangjiang Hi-Tech Park, ePudong, e-Shanghai.Kuyinkampani ephethwe ngokuphelele ye-Zhejiang Shangke Biomedical Co., Ltd. I-Shangke Bio izibophezele ocwaningweni nasekuthuthukiseni insimu yemithi eluhlaza esezingeni eliphezulu kakhulu, ihola ukuthuthukiswa kwemboni yamakhemikhali nge-biotechnology eluhlaza, futhi inikeza izinto ezintsha. imikhiqizo kanye nezinsizakalo ezisezingeni eliphezulu embonini yezemithi.Kuyibhizinisi lobuchwepheshe obuphezulu e-Shanghai futhi liyibhizinisi lobuchwepheshe obuphezulu laseShanghai "elikhethekile, elicwengisisiwe, elikhethekile nelisha".
Ibhizinisi eliyinhloko le-Suntech lihlanganisa: ukuthuthukiswa nokusebenzisa ama-enzyme e-biological, ukuthuthukiswa kanye nokukhiqizwa kwama-intermediate emithi, ama-API namakhemikhali asebenzayo.Imikhiqizo eyinhloko yenkampani yimikhiqizo ye-coenzyme, ehlanganisa i-NMN, i-NAD, i-NADP, i-NADH, i-NADPH, ama-enzyme ebhayoloji, izinto zokusetshenziswa kwemithi kanye neziphakathi.Amakhasimende kanye nozakwethu bale nkampani basemhlabeni wonke, futhi yakhe ubudlelwano bokubambisana obuseduze nezinkampani eziningi ezithaka imithi eNyakatho Melika, eYurophu, eNdiya naseChina.
Isikhathi sokuthumela: Jan-15-2021